Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (DUL.F) Q3 2023 Earnings

3AugConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-2.7

-2.22

-1.75

-1.27

Details

Expected EPS

-1.369695

Actual EPS

-2.0180173

Surprise EPS

-0.65

Surprise Percent

+47.33%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of -2.0180173 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.